COVAXIN: India's first indigenous covid-19 (corona) Vaccine.


image credit : Bharat Biotech Web. 


Covaxin is a India's first indigenous Covid-19 Vaccine. 
Bharat Biotech India Limited (BBIL) have get the permission for Clinical trials phase 2nd and 3rd by Central Drugs Standard Control Organization (CDSCO). 
This vaccine has been prepared at BSL-3 (Bio Safety Level-3) of Bharat Biotech in Hyderabad with the help of National Institute of Virology (NIV) of ICMR. 





NIV sent a strain of Covid-19 virus obtained from Asymptomatic patient to BBIL in May 2020. 
Company used the virus for development of inactivated vaccine. 

(Inactivated Vaccine : A vaccine which is prepared by dead virus usage) 

After Development of Covaxin, company started its pre-clinical trails on Rats & Guinea Pigs. 
Pre-clinical trail has been submitted successfully and now company get the permission for Clinical Trials phase 2nd and 3rd. 
Government expected that, Covaxin may be come before Independence Day 2020 (15 August 2020).

Recently ICMR issued some letters 


ICMR Letter regarding  COVAXIN 


click on image for clear vision. 


Steps of trial of Vaccine. 

Pre-clinical Trails : On animals. 

Human Clinical trial Phase 1: On some people 

Human clinical trial Phase 2: On 100 people 

Human clinical trials Phase 3: on 1000 people 


Zydus Cadila Healthcare Ltd. have also get the permission for Human Clinical trial phase 1st and 2nd by CDSCO. 










Comments

Post a Comment

Popular posts from this blog

International Yoga Day; 21 June

Sree Padmanabhaswamy Temple Case & Decision of Supreme Court.

One Nation One Ration Card